Allurion Technologies 주식 (NYSE: ALUR)

Allurion Technologies (NYSE:ALUR) 주식

Allurion Technologies

Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Allurion Technologies Inc

Allurion Technologies, Inc. Warrants, each whole warrant exercisable to purchase 1.420455 shares of common stock at an exercise price of $8.10 per share of common stock

WIIM

PINS

Pinterest shares are trading higher after Guggenheim upgraded the stock from Neutral to Buy and raised the price target from $39 to $40

Stifel analyst Chris O'Cull maintains Jack In The Box (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JACK#NASDAQ">JACK</a>) with a Hold and lowers the price target from $40 to $35.

News

Price Target

Analyst Ratings

JACK

Stifel Maintains Hold on Jack In The Box, Lowers Price Target to $35

COHR

Coherent shares are trading higher after Raymond James upgraded its rating on the stock from Outperform to Strong Buy despite lowering the price target from $110 to $91.

McCormick &amp; Company, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) will release its first-quarter financial results before the <a href="https://www.benzinga.com/quote/MKC/earnings">opening bell on Tuesday, March 25.</a>
Analysts expect the company to report quarterly earnings at 64 cents per share, up from 63 cents per share in the year-ago period. McCormick projects quarterly revenue of $1.61 billion, compared to $1.6 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Jan. 27, Barclays analyst Andrew Lazar maintained McCormick with an Equal-Weight rating and lowered the price target from $85 to $82.
With the recent buzz around McCormick, some investors may be eyeing potential gains from the company's dividends, too. Currently, McCormick offers an annual dividend yield of 2.25% and a quarterly dividend of 45 cents per share ($1.80 a year).
To figure out how to earn $500 monthly from McCormick, we start with the yearly target of $6,000 ($500 x 12 months).
Next, we take this amount and divide it by McCormick's $1.80 dividend: $6,000 / $1.80 = 3,333 shares.
So, an investor would need to own approximately $267,207 worth of McCormick, or 3,333 shares, to generate a monthly dividend income of $500.
Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $1.80 = 667 shares, or $53,473 to generate a monthly dividend income of $100.
Note that dividend yield can change on a rolling basis, as the dividend payment and stock price both fluctuate over time.
The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change.
For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60).
Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40).
Further, the dividend payment itself can also change over time, which can also impact the dividend yield. If a company increases its dividend payment, the dividend yield will increase even if the stock price remains unchanged. Similarly, if a company decreases its dividend payment, the dividend yield will decrease.
MKC Price Action: Shares of McCormick fell by 0.7% to close at $80.17 on Friday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44434941/how-to-earn-500-a-month-from-kb-home-stock-ahead-of-q1-earnings">How To Earn $500 A Month From KB Home Stock Ahead Of Q1 Earnings</a></li>
</ul>
Photo: Shutterstock

Earnings

Long Ideas

Markets

Trading Ideas

How To Earn $500 A Month From McCormick Stock Ahead Of Q1 Earnings

Stifel analyst W. Andrew Carter maintains Beacon Roofing Supply (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BECN#NASDAQ">BECN</a>) with a Hold and raises the price target from $122.55 to $124.35.

BECN

Stifel Maintains Hold on Beacon Roofing Supply, Raises Price Target to $124.35

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/03/21/final-trades-kinsale-capital-group-robinhood-markets-meta-and-yum-china.html">Halftime Report Final Trades</a>,&#8221; Bryn Talkington of Requisite Capital Management named Robinhood Markets, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) as <a href="https://www.benzinga.com/quote/HOOD/analyst-ratings">her final trade</a>.
Supporting his view, Compass Point analyst Ed Engel, on March 19, initiated coverage on Robinhood Markets with a Buy rating and announced a price target of $61.
Joshua Brown of Ritholtz Wealth Management said Kinsale Capital Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNSL#NYSE">KNSL</a>) goes up like every day and it's &#8220;crazy.&#8221;
As per the recent earnings news, Kinsale Cap reported quarterly earnings of $4.62 per share on Feb. 13, beating the analyst consensus estimate of $4.34 per share. The company reported quarterly sales of $412.123, missing the analyst consensus estimate of $416.708 million.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Stephen Weiss of Short Hills Capital Partners said Meta Platforms, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) has bottomed and it looks pretty cheap right now.
Last week, Meta Platforms CEO Mark Zuckerberg announced that the company's AI model family, ‘Llama', has reached a milestone of 1 billion downloads. On March 18, he posted a meme stating: &#8220;Me finding out Llama hit 1 Billion downloads.&#8221;
Joseph M. Terranova of Virtus Investment Partners picked Yum China Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>) as his final trade.
On Feb. 6, Yum China reported better-than-expected fourth-quarter adjusted earnings results. Additionally, the company raised its quarterly dividend by 50% and introduced a $360 million share buyback program.
Price Action:
<ul>
<li>Robinhood shares gained 1.6% to close at $44.36 on Friday.</li>
<li>Kinsale Capital rose 2.4% to settle at $470.04 during Friday's session.</li>
<li>Meta shares gained 1.8% to close at $596.25 on Friday.</li>
<li>Yum China shares rose 0.1% to settle at $52.28 during the session.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44434941/how-to-earn-500-a-month-from-kb-home-stock-ahead-of-q1-earnings">How To Earn $500 A Month From KB Home Stock Ahead Of Q1 Earnings</a></li>
</ul>
Image: Shutterstock

Media

HOOD

KNSL

YUMC

Robinhood, Meta, Yum China And A Financial Stock On CNBC's 'Final Trades'

Stephens &amp; Co. analyst Trey Grooms downgrades AZEK Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZEK#NYSE">AZEK</a>) from Overweight to Equal-Weight and maintains the price target from $58 to $58.

Downgrades

AZEK

Stephens & Co. Downgrades AZEK Co to Equal-Weight, Maintains Price Target to $58

James Hardie Industries shares are trading lower after the company acquired AZEK in a $8.75 billion cash-and-stock deal.

Stifel analyst Steven Wieczynski maintains Carnival (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) with a Buy and raises the price target from $30 to $31.

Stifel Maintains Buy on Carnival, Raises Price Target to $31

Truist Securities analyst Michael Roxland maintains Graphic Packaging Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPK#NYSE">GPK</a>) with a Hold and lowers the price target from $31 to $30.

Truist Securities Maintains Hold on Graphic Packaging Holding, Lowers Price Target to $30

Stephens &amp; Co. analyst Sudan Loganathan downgrades Elevation Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELEV#NASDAQ">ELEV</a>) from Overweight to Equal-Weight and lowers the price target from $5 to $1.

ELEV

Stephens & Co. Downgrades Elevation Oncology to Equal-Weight, Lowers Price Target to $1

Contracts

VCIG

VCI Global shares are trading higher after the company announced three AI infrastructure contracts totaling $33 million.

Shares of DNA testing company 23andMe Holding Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ME#NASDAQ">ME</a>) are <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">trading lower in premarket</a> on Monday after the firm filed for bankruptcy.
The company has voluntarily filed for Chapter 11 bankruptcy to enable a sale process that seeks to maximize its business value.
It plans to maintain normal operations throughout this period. The move follows the recent <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44095553/23andme-special-committee-rejects-acquisition-proposal-from-ceo-anne-wojcicki" rel="noreferrer noopener">rejection of a non-binding acquisition </a>offer from CEO Anne Wojcicki and her affiliates.
Pending court approval, the company intends to sell its assets under Chapter 11 or Section 363 of the U.S. Bankruptcy Code.
&#8220;After a thorough evaluation of strategic alternatives, we have determined that a court-supervised sale process is the best path forward to maximize the value of the business,&#8221; said Mark Jensen, Chair and member of the Special Committee of the Board of Directors.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/25/03/44434720/defense-secretary-slashes-580-million-in-wasteful-spending-targets-overdue-overpriced-projects" rel="noreferrer noopener">Defense Secretary Slashes $580 Million In Wasteful Spending—Targets Overdue, Overpriced Projects</a>
&#8220;We expect the court-supervised process will advance our efforts to address the operational and financial challenges we face, including further cost reductions and the resolution of legal and leasehold liabilities.&#8221;
23andMe will hire an independent investment banker to gather bids over a 45-day timeframe, and if several offers are received, an auction will take place to optimize asset value.
Any prospective buyers must adhere to legal standards for customer data privacy. The sale process will also require regulatory approval.
As part of its bankruptcy proceedings, 23andMe has submitted motions to lower operational expenses, which includes rejecting specific real estate leases. The company is also requesting court approval to continue paying employee salaries and compensating suppliers throughout the process.
Furthermore, 23andMe aims to address outstanding legal matters stemming from the cyber incident that occurred in October 2023 during the bankruptcy process.
23andMe has secured a commitment for $35 million in debtor-in-possession financing from JMB Capital Partners. This funding, along with operational cash flow, is expected to support the company throughout the restructuring process.
Price Action: ME shares traded lower by 44.1% at $0.9999 in premarket at last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/03/44445205/d-wave-unveils-new-blockchain-architecture-to-slash-energy-usage" target="_blank" rel="noreferrer noopener">D-Wave Unveils New Blockchain Architecture To Slash Energy Usage</a></li>
</ul>
Photo via Shutterstock.

Equities

Movers

General

Why Is DNA Test Provider 23andMe Stock Tumbling Today?

VCI Global Announces Three AI Infrastructure Contracts Totaling $33M

SMTK

Smartkem Signs MoU With RiTdisplay To Integrate Smartkem's OTFT Process Into Gen2.5 Line

Biotech

ICCM

IceCure Medical Announces Presentation Of Interim Results From ICESECRET Study At European Association of Urology Conference Showing 88.7% Recurrence-Free Rate

Icon Energy Corp. ("Icon" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICON#NASDAQ">ICON</a>), an international shipping company that provides worldwide seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels, announced today that it has entered, through a separate wholly-owned subsidiary, into (i) a definitive agreement with an unaffiliated third party to bareboat charter-in, with the option to eventually purchase, a 2020-built, scrubber-fitted, Eco, Ultramax, dry bulk carrier with a carrying capacity of 63,668 dwt, as well as (ii) a time charter-out contract with an unaffiliated dry bulk operator, securing the employment of the same vessel for a period of 9 to 12 months. Icon intends to operate the vessel under the name Charlie.
Expansion. Icon expects to take delivery of the M/V Charlie between May and August 2025, subject to the satisfaction of certain customary closing conditions. Icon has made an advance payment of $2.75 million and will pay an additional $2.75 million upon delivery, followed by a hire rate of $7,500 per day over a three-year bareboat charter period. At the end of that period, Icon has the option to purchase the vessel for $18.0 million. Icon expects to finance those payments with a combination of cash on hand and cash from operations, as well as proceeds from loan agreements or other financing arrangements it will seek to enter into closer to the potential exercise of the purchase option.

ICON

Icon Energy Announces Bareboat Charter-In Of Ultramax Vessel M/V Charlie For Up To 12 Months; Advance Payment $2.75M With $7,500 Daily Hire; Purchase Option At $18M

Actelis Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASNS#NASDAQ">ASNS</a>) reported quarterly losses of $(0.85) per share which missed the analyst consensus estimate of $(0.53) by 60.38 percent. The company reported quarterly sales of $7.800 million which missed the analyst consensus estimate of $9.698 million by 19.57 percent.

Earnings Misses

ASNS

Actelis Networks FY 2024 GAAP EPS $(0.85) Misses $(0.53) Estimate, Sales $7.800M Miss $9.698M Estimate

Trade tensions, <a href="https://www.benzinga.com/topic/federal-reserve">Fed policy shifts</a> and weakening sentiment are creating a stormy outlook for the global economy.
JPMorgan's Bruce Kasman just upped the ante on recession risks, pegging the odds of a 2025 U.S./global downturn at 40%. That's not just a number—it's a warning shot for investors navigating an increasingly volatile landscape.
<h2 class="wp-block-heading">Trade War Fears Are Back &#8211; ETFs Are Already Reacting</h2>
Kasman's outlook hinges on one major factor: trade policy. With tariffs expected to push the effective U.S. rate above 10%, he sees a 0.5% GDP drag next year. But the real risk? A domino effect. 
If business sentiment cracks, capital expenditures slow and inflation limits Fed maneuverability, markets could turn defensive fast.
Investors aren't waiting for confirmation &#8211; ETF flows are already shifting. The iShares MSCI Emerging Markets ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EEM#NYSE">EEM</a>) has seen a surge in outflows as investors brace for trade turbulence. 
Meanwhile, defensive plays like the Utilities Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) and iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) are catching bids as risk appetite wanes.
Read Also: <a href="https://www.benzinga.com//node/44449713">Jerome Powell&#8217;s Stagflation Fears, Mark Cuban&#8217;s Economic Queries, And Ray Dalio&#8217;s Debt Warning: This Week In Economics</a>
<h2 class="wp-block-heading">Can The Fed Hold The Line?</h2>
The Fed isn't rushing to cut rates despite rising trade war concerns. Kasman notes that while policymakers remain "asymmetric" &#8211; ready to ease in a labor market downturn but unwilling to hike on strong growth &#8211; this stance leaves little cushion if sentiment nosedives.
That's a potential headwind for growth-focused ETFs like Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which relies on a Fed-friendly backdrop.
But it's not all doom and gloom. A front-loaded boost in global trade is temporarily lifting manufacturing ETFs, with the Industrial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>) seeing inflows as global industrial production spikes.
The question is: how long does that last before trade war fears fully set in?
<h2 class="wp-block-heading">ETF Playbook For Recession Risks</h2>
With uncertainty mounting, ETF investors are playing both offense and defense. Those bracing for more pain are rotating into SPDR Gold Shares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>) and Vanguard Consumer Staples ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VDC#NYSE">VDC</a>), while bargain hunters are eyeing SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) for potential buy-the-dip opportunities.
Bottom line? 
The 40% recession probability isn't just a macro call &#8211; it's already reshaping ETF positioning. If sentiment sours further, this shift is only getting started.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com//node/44450390">Charlie Munger&#8217;s Investment Wisdom: &#8216;If People Weren&#8217;t So Often Wrong, We Wouldn&#8217;t Be So Rich&#8217;</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Macro Economic Events

Sector ETFs

Broad U.S. Equity ETFs

Emerging Market ETFs

Economics

Federal Reserve

ETFs

iShares Trust Barclays 20+ Year Treasury Bond Fund

Trade Wars, Fed Moves And A 40% Recession Risk - Is Your Portfolio Ready?

Dividends

PSBD

Palmer Square Capital BDC Inc. Announces Q1 Supplemental Dividend Of $0.03

Press Releases

Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program

Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market

Allurion Relaunches in France

Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity

Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Allurion to Participate in Upcoming Investor Conferences

Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity

Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025

Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence

Comments

Allurion Technologies

뉴스

파트너 / 기고자

벤징가 글로벌